This review examines the role of nitric oxide (NO) in sepsis-induced vasoplegia and explores methylene blue (MB) as a potential treatment for refractory septic shock. NO contributes to excessive vasodilation in sepsis by activating the guanylate cyclase-cyclic guanosine monophosphate (cGMP) pathway, leading to severe vasoplegic shock. MB inhibits this pathway,
